Results 41 to 50 of about 1,772,507 (392)
Varicella: to vaccinate or not to vaccinate? [PDF]
Archives of Disease in Childhood, 1998 Editor,—I am in complete agreement with Dr Aebi that strategies for delivering varicella vaccine effectively are critical to the success of immunisation programmes.1 In the USA great efforts are being made in this direction. Nevertheless, despite the licensure of varicella vaccine for routine use in the United …
openaire +5 more sources
Acknowledgement to Reviewers of Vaccines in 2017
Vaccines, 2018 Peer review is an essential part in the publication process, ensuring that Vaccines maintains high quality standards for its published papers.[...]
Vaccines Editorial Office
doaj +1 more source
BMC Medical Research Methodology, 2021 Background Randomized controlled trials are considered the gold standard to evaluate causal associations, whereas assessing causality in observational studies is challenging.
Emilia Gvozdenović +6 more
doaj +1 more source
Vaccines, 2021 COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology.
T. H. Thi +5 more
semanticscholar +1 more source
Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism [PDF]
, 2009 Attempts to develop therapeutic vaccines against cervical cancer have been proven difficult. One of the major causes of the failure is due to the use of the wrong mouse models based on transplantable tumours in testing the efficacy of vaccines.
Germain J. Fernando +3 more
core +2 more sources
COVID-19 vaccines: where we stand and challenges ahead
Cell Death and Differentiation, 2021 In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects.
Guido Forni +26 more
semanticscholar +1 more source
Acknowledgement to Reviewers of Vaccines in 2018
Vaccines, 2019 Rigorous peer-review is the corner-stone of high-quality academic publishing. [...]
Vaccines Editorial Office
doaj +1 more source
COVID-19 vaccines: modes of immune activation and future challenges
Nature reviews. Immunology, 2021 The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide dissemination across the global population and the inclusion of newly licensed mRNA platforms.
J. Teijaro, D. Farber
semanticscholar +1 more source
Mucosal vaccines — fortifying the frontiers
Nature reviews. Immunology, 2021 Mucosal vaccines offer the potential to trigger robust protective immune responses at the predominant sites of pathogen infection. In principle, the induction of adaptive immunity at mucosal sites, involving secretory antibody responses and tissue ...
E. Lavelle, Ross W. Ward
semanticscholar +1 more source
Overview of vaccines and vaccination [PDF]
Molecular Biotechnology, 2005 Of the 80-plus known infectious agents pathogenic for humans, there are now more than 30 vaccines against 26 mainly viral and bacterial infections and these greatly minimize subsequent disease and prevent death after exposure to those agents. This article describes the nature of the vaccines, from live attenuated agents to subunits, their efficacy and ...
openaire +4 more sources